Journey Medical Corporation (DERM): History, Ownership, Mission, How It Works & Makes Money

Ever wondered how a dermatology-focused pharmaceutical company operates and generates revenue? Journey Medical Corporation (DERM), a commercial-stage company founded in 2014 by Fortress Biotech, Inc., specializes in marketing FDA-approved prescription drugs for dermatological conditions, but how exactly does it work and make money? With $56.1 million in total revenues for the full year ended December 31, 2024, and a strategic focus on acquiring and commercializing innovative dermatology products, Journey Medical's approach is worth exploring.

Journey Medical, headquartered in Scottsdale, Arizona, leverages its team's extensive experience in the dermatology market to identify and commercialize undervalued assets. Currently, the company markets eight FDA-approved branded and two generic products aimed at treating common skin conditions. Keep reading to find out more about Journey Medical Corporation!

Journey Medical Corporation (DERM) History

Journey Medical Corporation's Founding Timeline

Year established

Journey Medical Corporation was established in 2014.

Original location

The company is headquartered in Scottsdale, Arizona.

Founding team members

Although specific names of the founding team members are not readily available in the provided search snippets, it is known that the company was formed to focus on acquiring and commercializing prescription dermatology products.

Initial capital/funding

Information regarding the initial capital or funding of Journey Medical Corporation during its founding in 2014 is not available in the provided search results.

Journey Medical Corporation's Evolution Milestones

Journey Medical Corporation's Transformative Moments

• Strategic Acquisitions: Journey Medical has strategically acquired and licensed various dermatology products, enhancing its portfolio and market position.
• Focus on Prescription Dermatology: The company's consistent focus on prescription dermatology products has allowed it to carve out a niche in the market and cater to specific patient needs.
• Key Leadership Changes: Changes in leadership roles have influenced the strategic direction and operational efficiency of Journey Medical, adapting to market dynamics and growth opportunities.
• Financial Restructuring and Debt Management: Efforts to manage debt and restructure finances have provided Journey Medical with greater financial flexibility and stability, enabling it to pursue growth initiatives.

For more insights into the company's guiding principles, explore: Mission Statement, Vision, & Core Values of Journey Medical Corporation (DERM).

Journey Medical Corporation (DERM) Ownership Structure

Understanding Journey Medical's ownership structure provides insights into its control and governance. The company's shares are distributed among various institutional and individual investors, shaping its strategic direction.

Journey Medical Corporation's Current Status

Journey Medical Corporation is a publicly traded company, meaning its shares are available for purchase on the open market. It operates under the ticker symbol DERM. As a publicly-traded entity, it is subject to regulations and reporting requirements.

Journey Medical Corporation's Ownership Breakdown

The ownership of Journey Medical Corporation is distributed among various shareholders, including institutional investors, individual shareholders, and company insiders. The following table summarizes the ownership breakdown:

Journey Medical Corporation's Leadership

The leadership team guides the strategic direction and operational execution of Journey Medical Corporation. Here are some key members:

• Brenton L. Saunders: Chairman of the Board
• Shawn T. O'Brien: Chief Executive Officer

For more insights into Journey Medical Corporation's financial stability, explore Breaking Down Journey Medical Corporation (DERM) Financial Health: Key Insights for Investors.

Journey Medical Corporation (DERM) Mission and Values

Journey Medical Corporation focuses on acquiring, commercializing, and marketing pharmaceutical products, primarily in dermatology. The company aims to improve patients' lives by addressing skin health needs with effective and accessible treatments.

Journey Medical Corporation's Core Purpose

Official mission statement

While Journey Medical Corporation does not have a single, publicly available official mission statement, their core purpose can be inferred from their business activities and public statements. It is centered around:

• Identifying, developing, and commercializing dermatological products to address unmet patient needs.
• Expanding access to quality skin care treatments.
• Building a portfolio of trusted brands in the dermatology space.

Vision statement

Similarly, Journey Medical Corporation's vision statement is not explicitly declared, but can be understood through their strategic objectives and long-term goals:

• To become a leading dermatology company with a diverse and innovative product portfolio.
• To establish a strong market presence and brand recognition within the dermatology sector.
• To drive sustainable growth and create value for shareholders through strategic acquisitions and product development.

Company slogan/tagline

Journey Medical Corporation does not have a widely publicized official slogan or tagline. However, considering their focus, a possible implied tagline could be:

• 'Dedicated to Skin Health.'
• 'Advancing Dermatology, Improving Lives.'
• 'Your Journey to Healthy Skin Starts Here.'

To gain more insights into the company's financial standing, explore Breaking Down Journey Medical Corporation (DERM) Financial Health: Key Insights for Investors.

Journey Medical Corporation (DERM) How It Works

Journey Medical Corporation focuses on acquiring, developing, and commercializing pharmaceutical products, primarily for the treatment of skin diseases.

Journey Medical Corporation's Product/Service Portfolio

Journey Medical Corporation's Operational Framework

Journey Medical operates through a focused approach on dermatology by:

• Acquisition and Development: Identifying and acquiring established dermatology products or developing new formulations to address unmet needs in the market.
• Commercialization: Marketing and selling its portfolio of products through a specialized sales force that targets dermatologists and other healthcare providers.
• Manufacturing and Supply Chain: Managing the manufacturing and supply chain to ensure consistent product availability and quality.
• Patient Access Programs: Implementing programs to support patient access to medications, including co-pay assistance and patient education initiatives.

Journey Medical Corporation's Strategic Advantages

Journey Medical distinguishes itself through several key competitive advantages:

• Focused Dermatology Portfolio: A concentrated portfolio of dermatology products allows for specialized sales and marketing efforts.
• Established Brand Recognition: Many of Journey Medical's products have established brand recognition and a history of use, providing a competitive edge.
• Experienced Management Team: A management team with experience in the dermatology market.
• Efficient Operational Model: Focus on profitability through cost control. For more information, refer to: Mission Statement, Vision, & Core Values of Journey Medical Corporation (DERM).

Journey Medical Corporation (DERM) How It Makes Money

Journey Medical Corporation focuses on the acquisition, development, and commercialization of pharmaceutical products, primarily for the treatment of skin diseases. The company generates revenue through the sale of these branded prescription drugs within the U.S. market.

Journey Medical Corporation's Revenue Breakdown

As Journey Medical Corporation's financial data for the fiscal year 2024 has not yet been fully compiled and released, an exact revenue breakdown is not currently available. However, we can analyze the general trends based on the company's focus and available information.

Journey Medical Corporation's Business Economics

Journey Medical operates within the branded prescription dermatology market. Its business economics are influenced by several key factors:

• Pricing Strategy: The company employs a premium pricing model reflective of branded pharmaceuticals, but this is balanced against ensuring patient access through various insurance and patient assistance programs.
• Gross Margins: Branded pharmaceuticals typically command high gross margins, often in excess of 70%, due to intellectual property protection and market exclusivity.
• Operating Expenses: A significant portion of revenue is allocated to sales and marketing to promote products to dermatologists and patients. R&D expenses are also important as Journey Medical continues to develop and acquire new products.
• Acquisition Strategy: Acquiring established dermatology products can provide immediate revenue streams and synergies, but also involves integration costs and potential risks.

Journey Medical Corporation's Financial Performance

Analyzing Journey Medical's financial performance involves looking at key metrics that demonstrate its operational efficiency and profitability. As the 2024 fiscal year is still in progress, complete data is not yet available. However, based on previous trends and available information, here's what to monitor:

• Revenue Growth: Track the year-over-year revenue growth, particularly the contribution from newer products like QBREXZA and EXELDERM.
• Gross Profit Margin: Monitor the gross profit margin to ensure it remains healthy, reflecting effective cost management and pricing strategies.
• Operating Income: This indicates the profitability of core operations after accounting for operating expenses.
• Net Income: The bottom-line profitability, which is influenced by interest expenses, taxes, and any one-time gains or losses.
• Cash Flow: Analyzing cash flow from operations, investing, and financing activities provides insights into the company's liquidity and financial stability.
• Debt Levels: Keep an eye on debt levels, as acquisitions are often financed with debt. Managing debt effectively is crucial for long-term financial health.

To gain more insight into the company's values, check out Mission Statement, Vision, & Core Values of Journey Medical Corporation (DERM).

Journey Medical Corporation (DERM) Market Position & Future Outlook

Journey Medical Corporation is positioning itself for future growth, particularly with the launch of Emrosi™ and strategic focus on its dermatology product portfolio; however, the company faces financial challenges and competitive pressures.

Here's an overview of Journey Medical's market position, opportunities, and challenges as of April 2025. Don't forget to check out Mission Statement, Vision, & Core Values of Journey Medical Corporation (DERM).

Competitive Landscape

Opportunities & Challenges

Industry Position

Journey Medical Corporation is a commercial-stage pharmaceutical company focused on dermatology. Key points regarding its industry position include:

• Focus on Dermatology: Journey Medical specializes in marketing and selling FDA-approved prescription pharmaceutical products for dermatological conditions.
• Product Portfolio: As of April 2025, the company markets seven branded and two generic products.
• Recent Approval: Emrosi™ (minocycline hydrochloride extended-release capsules, 40 mg) was approved by the FDA in November 2024 for treating inflammatory lesions of rosacea in adults.
• Financial Performance:
  • Total revenues for 2024 were $56.1 million.
  • Net product revenue in 2024 was $55.1 million, compared to $59.7 million in 2023.
  • The company experienced a net loss of $14.7 million in 2024.
• Market Share: While specific market share data isn't available, Journey Medical aims to capture a significant portion of the rosacea treatment market with Emrosi™, previously dominated by Oracea®.